Inventor · disambiguated record
Christos Tzitzilonis
Also filed as: TZITZILONIS CHRISTOS
14 granted patents·4 pending applications·33 citations·filing 2016–2024
89Inventor score
Files withROCHE SEQUENCING SOLUTIONS INC9REVOLUTION MEDICINES INC6GENIA TECH INC2MAZE THERAPEUTICS INC1
Top patents by PatentIndex Score
18 records- 0194US12037366B2OMPG variantsROCHE SEQUENCING SOLUTIONS INC·Filed 2023·Granted Jul 16, 2024·2 cites·20 claims
- 0294US11767348B2OmpG variantsROCHE SEQUENCING SOLUTIONS INC·Filed 2020·Granted Sep 26, 2023·4 cites·24 claims
- 0393US10227645B2Alpha-hemolysin variantsGENIA TECH INC·Filed 2016·Granted Mar 12, 2019·11 cites·19 claims
- 0491US10752948B2Alpha-hemolysin variantsROCHE SEQUENCING SOLUTIONS INC·Filed 2019·Granted Aug 25, 2020·5 cites·25 claims
- 0590US10752658B2OmpG variantsROCHE SEQUENCING SOLUTIONS INC·Filed 2016·Granted Aug 25, 2020·7 cites·18 claims
- 0687US12435114B2OmpG variantsROCHE SEQUENCING SOLUTIONS INC·Filed 2024·Granted Oct 7, 2025·0 cites·20 claims
- 0786US11001611B2Site-specific bio-conjugation methods and compositions useful for nanopore systemsROCHE SEQUENCING SOLUTIONS INC·Filed 2018·Granted May 11, 2021·2 cites·9 claims
- 0885US12479893B2Site-specific bio-conjugation methods and compositions useful for nanopore systemsROCHE SEQUENCING SOLUTIONS INC·Filed 2023·Granted Nov 25, 2025·0 cites·12 claims
- 0984US11261488B2Alpha-hemolysin variantsROCHE SEQUENCING SOLUTIONS INC·Filed 2020·Granted Mar 1, 2022·1 cites·20 claims
- 1075US11739093B2Substituted pyrazolopyrazines, imidazopyrazines and [1,2,4]triazolopyrazines as allosteric SHP2 inhibitorsREVOLUTION MEDICINES INC·Filed 2019·Granted Aug 29, 2023·1 cites·18 claims
- 1173US11866464B2Site-specific bio-conjugation methods and compositions useful for nanopore systemsROCHE SEQUENCING SOLUTIONS INC·Filed 2021·Granted Jan 9, 2024·0 cites·9 claims
- 1271US12365688B2Substituted pyrazolopyrazines, imidazopyrazines and [1,2,4]triazolopyrazines as allosteric SHP2 inhibitorsREVOLUTION MEDICINES INC·Filed 2023·Granted Jul 22, 2025·0 cites·36 claims
- 1370US2024067636A1Pyridine, pyrazine, and triazine compounds as allosteric shp2 inhibitorsREVOLUTION MEDICINES INC·Filed 2023·Application pending·0 cites
- 1470US2024101577A1Polycyclic compounds as allosteric shp2 inhibitorsREVOLUTION MEDICINES INC·Filed 2023·Application pending·0 cites
- 1566US11702411B2Pyridine, pyrazine, and triazine compounds as allosteric SHP2 inhibitorsREVOLUTION MEDICINES INC·Filed 2020·Granted Jul 18, 2023·0 cites·6 claims
- 1660US11673901B2Polycyclic compounds as allosteric SHP2 inhibitorsREVOLUTION MEDICINES INC·Filed 2020·Granted Jun 13, 2023·0 cites·19 claims
- 1758US2024199546A1Inhibitors of solute carrier family 6a member 19 (slc6a19) and methods of use thereofMAZE THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 1841US2020216887A1Nanopore sequencing complexesGENIA TECH INC·Filed 2017·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Christos Tzitzilonis files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →